All public logs

Combined display of all available logs of Beacon. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

13:19, 4 December 2023 Francine talk contribs created page Self-help Groups List (University Cancer Center Frankfurt) (Created page with "{{forpatients}} Go back to University Cancer Center Frankfurt page '''Primary purpose''': The website provides a list of the active self-help groups in the hospital. '''Access Information''': Information [https://www.uct-frankfurt.de/selbsthilfe.html].")
13:17, 4 December 2023 Francine talk contribs created page Novel Therapies and Diagnostic Methods (University Cancer Center Frankfurt) (Created page with "{{forpatients}} Go back to University Cancer Center Frankfurt page === Diagnostics === {| class="wikitable" ! Radiology !! !! !! |- | '''Type''' || '''Name''' || '''Availibility''' || '''Uses per year''' |- | Machine || CT scanners || Yes || |- | Machine || MRI (specify the strength and field of the techniques) || Yes || |- | Machine || Mammography (please specify analogic mammography or digital) || Yes (digital) || |- | Machine || Ultrasound || Yes || |- |...")
13:16, 4 December 2023 Francine talk contribs created page Events: UCT Events (University Cancer Center Frankfurt) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to University Cancer Center Frankfurt page '''Primary purpose:''' To provide information about various types of cancer, and their associated symptoms, and to facilitate connections with self-help groups and UCT partners for patients, relatives, and interested individuals. '''Target audience:''' Patients, relatives and the general public. '''Access Information:''' Information [https://www.uct-frankfurt.de/...")
13:15, 4 December 2023 Francine talk contribs created page Trainings: UCT Trainings (University Cancer Center Frankfurt) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to University Cancer Center Frankfurt page '''Primary purpose:''' To promote interdisciplinary training for healthcare professionals, organize further education, and provide information events for patients, relatives, and the general public. '''Target audience:''' Healthcare professionals, students, nurses, doctors, scientists, patients and the general public. '''Access Information:''' Information [https:...")
13:13, 4 December 2023 Francine talk contribs created page Experts (University Cancer Center Frankfurt) (Created page with "{{forproviders}} Go back to University Cancer Center Frankfurt page '''[https://www.uct-frankfurt.de/ueber-uns/onkologisches-zentrum/universitaetsklinikum.html Breast Center]''' '''[https://www.uct-frankfurt.de/ueber-uns/onkologisches-zentrum/universitaetsklinikum.html Children's Oncology Center]''' '''[https://www.uct-frankfurt.de/ueber-uns/onkologisches-zentrum/universitaetsklinikum.html Gynecological Cancer]''' '''[https://www.uct-frankfurt.de/ueber-uns/onkolo...")
13:11, 4 December 2023 Francine talk contribs created page Trials (University Cancer Center Frankfurt) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to University Cancer Center Frankfurt page '''NCTID''': NCT04821622 '''Title''': Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC '''Study Summary''': The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination with enzalutamide in participants with DDR-deficient mCSPC. '''Sponsor''': Pfiz...")
13:06, 4 December 2023 Francine talk contribs created page Trials (Charité Comprehensive Cancer Center) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Charité Comprehensive Cancer Center page '''NCTID''': NCT02951767 '''Title''': A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1) '''Study Summary''': This Phase II, single-arm study is designed to evaluate the effect of atezolizumab treatment in participants with locally advanced or metastatic urothelial bladder cancer. Participants will...")
12:48, 4 December 2023 Francine talk contribs created page Trials (National Cancer Center Dresden) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to National Cancer Center Dresden page '''NCTID''': NCT03430843 '''Title''': A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma '''Study Summary''': The purpose of this study is to evaluate the efficacy and safety of tislelizumab as second line treatment in participants with advanced unresectable/metastatic ESC...")
12:37, 4 December 2023 Francine talk contribs created page Trials (Institut Sainte Catherine) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Sainte Catherine page '''NCTID''': NCT01300143 '''Title''': Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma '''Study Summary''': Indication : Hepatocellular carcinoma, maximum size 9 cm, with single or multiple nodes whose total tumor mass can technically be irradiated, non-resectable, and...")
12:28, 4 December 2023 Francine talk contribs created page Trials (Centre Henri Becquerel) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Centre Henri Becquerel page '''NCTID''': NCT04712097 '''Title''': A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma '''Study Summary''': This study will evaluate the efficacy and safety of...")
23:59, 3 December 2023 Francine talk contribs created page Trials (Georges-François Leclerc Cancer Center) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Georges-François Leclerc Cancer Center page '''NCTID''': NCT02947685 '''Title''': Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer '''Study Summary''': The primary objective of this study is to demonstrate that the combination of palbociclib with anti-HER2 therapy plus endocrine therapy is superior to anti-HER2-based therapy plus endocrin...")
23:52, 3 December 2023 Francine talk contribs created page Trials (Institut Godinot) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Godinot page '''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabine alone, in patients with metastatic Pancreatic Ductal Aden...")
23:43, 3 December 2023 Francine talk contribs created page Trials (Institut du Cancer de Montpellier) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut du Cancer de Montpellier page '''NCTID''': NCT00875667 '''Title''': A Study to Determine the Efficacy of Lenalidomide Versus Investigator’s Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL) '''Study Summary''': To evaluate the safety and efficacy of lenalidomide versus investigator choice in patients with relapsed or refractory mantle cell lymphoma. '''Sponsor''':...")
23:37, 3 December 2023 Francine talk contribs created page Trials (Comprehensive Cancer Center Jean Perrin) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Comprehensive Cancer Center Jean Perrin page '''NCTID''': NCT01491737 '''Title''': A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer '''Study Summary''': This randomized, open-label, two-arm, multi-center, Phase II study will eva...")
23:30, 3 December 2023 Francine talk contribs created page Trials (Cancer Institute Strasbourg Europe) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Cancer Institute Strasbourg Europe page '''NCTID''': NCT04717414 '''Title''': An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions '''Study Summary''': The purpose of this Phase 3 study is to evaluate the efficacy and safety of Luspa...")
23:15, 3 December 2023 Francine talk contribs created page Trials (Eugène Marquis Cancer Centre) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Eugène Marquis Cancer Centre page '''NCTID''': NCT02444000 '''Title''': gliomasPCV Only in 1p/19q Codeleted Anaplastic Gliomas '''Study Summary''': Patients with 1p/19q-codeleted anaplastic gliomas treated with RT + PCV are at risk of neurocognitive deterioration. Treating these patients with PCV alone (could reduce the risk of neurocognitive deterioration without impairing overall survival. '''Sp...")
23:06, 3 December 2023 Francine talk contribs created page Trials (Institut de Cancérologie de lOuest (ICO) - Integrated Center for Oncology) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut de Cancérologie de lOuest (ICO) - Integrated Center for Oncology page '''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabine...")
23:03, 3 December 2023 Francine talk contribs created page Trials (Institut de Cancérologie de l'Ouest (ICO) - Integrated Center for Oncology) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut de Cancérologie de l'Ouest (ICO) - Integrated Center for Oncology page '''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabin...")
22:57, 3 December 2023 Francine talk contribs created page Trials (APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC)) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC) page '''NCTID''': NCT04622319 '''Title''': A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) '''Study Summary''': Patients with HER2-positive primary breast cancer (BC) who...")
22:57, 2 December 2023 Larysse talk contribs created page Data Dictionary: Finnish Mobile Clinic Examination (Created page with "Go back to Finland page. Source: [https://thl.fi/en/web/thl-biobank/for-researchers/sample-collections/finnish-mobile-clinic-collections-1966-1980-autoklinikka-]. {| class="wikitable" ! Questionnaires and Interviews |- | Sociodemographic factors (age, marital status, region, occupation etc.) |- | Lifestyle |- | Smoking, exercise |- | Alcohol consumption, coffee drinking |- | Sauna bathing |- | Hobbies |- | Dietary factors (foodstuffs, nutrients) |- | Work...")
05:24, 2 December 2023 Larysse talk contribs created page Data Dictionary: National FinHealth 2017 Study (Created page with "Go back to Finland page. Source: []. {| class="wikitable" ! Questionnaires content |- | What is your present state of health? |- | Do you have any longstanding illness or health problem? |- | Are you limited because of a health problem in activities people usually do? What is your limitation level? |- | Have you been limited for at least the past 6 months? |- | Has a doctor diagnosed or treated you for any of the following diseases during the past last 12 months? C...")
04:57, 2 December 2023 Larysse talk contribs created page Data Dictionary: Register of Primary Health Care Visits (Created page with "Go back to Finland page. Source:[https://thl.fi/en/web/thlfi-en/statistics-and-data/data-and-services/register-descriptions/register-of-primary-health-care-visits#data%20content]. {| class="wikitable" ! Data about the service event |- | Client's personal identity number (encrypted in the register) |- | Client's municipality of residence |- | Postcode of the client's place of residence |- | Service provider |- | Service unit of the service provider |- | Event record...")
22:16, 1 December 2023 Francine talk contribs created page Trials (Centre François Baclesse) (Created page with "'''NCTID''': NCT01827943 '''Title''': Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer '''Study Summary''': In the absence of standard treatment in this indication, this test evaluates a new drug type targeted therapy in this indication, evaluating its efficacy in terms of tumor response and survival. '''Sponsor''': Institut Bergonié '''Intervention''': Temsirolimus '''Start Date''': 2009-06 '''Last Updated''...")
22:10, 1 December 2023 Francine talk contribs created page Trials (University Cancer Institute Toulouse-Oncopole) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to University Cancer Institute Toulouse-Oncopole page '''NCTID''': NCT06112314 '''Title''': IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) '''Study Summary''': This is a phase 3, randomized, controlled study of IMC-F106C plus nivolumab compared to standard nivolumab regimens in HLA-A*02:01-positive participants with previously untreated advanced mel...")
22:04, 1 December 2023 Francine talk contribs created page Trials (Institut Paoli-Calmettes) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Paoli-Calmettes page '''NCTID''': NCT04070443 '''Title''': Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase '''Study Summary''': The investigators hypothesize that, in newly diagnosed de novo chronic phase CML patients, an induction treatment with ponatinib for 6 months should increase the rate of patients reaching a stable...")
21:58, 1 December 2023 Francine talk contribs created page Trials (Institut Curie) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Curie page '''NCTID''': NCT03875573 '''Title''': Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: '''Study Summary''': Neo-CheckRay is a multicenter, open-label phase II study that randomizes luminal B breast cancer subjects candidate for neo-adjuvant chemotherapy in a 1:1:1 ratio in 3 arms:...")
21:52, 1 December 2023 Francine talk contribs created page Trials (Léon Bérard Center) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Léon Bérard Center page '''NCTID''': NCT01222767 '''Title''': Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy '''Study Summary''': This is a phase II Multicenter, Open-label, Clinical and Pharmacokinetic Study of Zalypsis® (PM00104) in Patients with Unresectable Loc...")
21:28, 1 December 2023 Francine talk contribs created page Trials (Oulu University Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Oulu University Hospital page '''NCTID''': NCT04607421 '''Title''': A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer '''Study Summary''': The purpose of this study is to evaluate two study medicines (encorafenib plus cetuximab) taken alone or together with standard chemotherapy for the potential treatment of colorectal c...")
21:22, 1 December 2023 Francine talk contribs created page Trials (Cancer Center of Kuopio University Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Cancer Center of Kuopio University Hospital page '''NCTID''': NCT04597125 '''Title''': Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH '''Study Summary''':...")
21:17, 1 December 2023 Francine talk contribs created page Trials (TAYS Cancer Centre Tampere University Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to TAYS Cancer Centre Tampere University Hospital page '''NCTID''': NCT04736706 '''Title''': A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012) '''Study Summary''': The goal of...")
21:11, 1 December 2023 Francine talk contribs created page Trials (Turku University Hospital Cancer Centre) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Turku University Hospital Cancer Centre page '''NCTID''': NCT03486873 '''Title''': Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) '''Study Summary''': The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in part...")
21:03, 1 December 2023 Francine talk contribs created page Trials (Institut Jules Bordet) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Jules Bordet page '''NCTID''': NCT04966715 '''Title''': Inferior Epigastric Lymph Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Colorectal Peritoneal Metastases '''Study Summary''': In this study, the investigators propose to systematically collect and analyse epigastric lymph nodes during complete cytureductive surgery in patients with colorectal carcinomatosis, in order to d...")
20:55, 1 December 2023 Francine talk contribs created page Trials (Masaryk Memorial Cancer Institute) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Masaryk Memorial Cancer Institute page '''NCTID''': NCT05603351 '''Title''': Prostate Cancer Screening With Abbreviated MRI Protocol '''Study Summary''': Prostate cancer is one of the most common malignancies in the male population with incidence and mortality rates comparable to breast cancer in women, but in contrast, a population screening program that would fulfill all the recommended criteria is n...")
20:52, 1 December 2023 Francine talk contribs created page Trials (Motol University Hospital) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Motol University Hospital page '''NCTID''': NCT02447666 '''Title''': Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML) '''Study Summary''': Indication Treatment of pediatric subjects with newly diagnosed advanced myelodysplastic syndrome (MDS) or juvenile myelomonocytic leukemia (JMML) prior to hematop...")
20:50, 1 December 2023 Francine talk contribs created page Trials (Vejle Cancer Centre - The Patients’ Cancer Hospital part of Lillebaelt Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Vejle Cancer Centre – The Patients’ Cancer Hospital part of Lillebaelt Hospital page '''NCTID''': NCT05573022 '''Title''': Impact of a Patient Decision Aid Intervention '''Study Summary''': Studies evaluating decisions aids have used a wide range of outcome measures as well as formats and settings. Most studies have focused on patient decision aids used either within the consultation or delivered...")
20:49, 1 December 2023 Francine talk contribs created page Trials (The Patients’ Cancer Hospital part of Lillebaelt Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to The Patients’ Cancer Hospital part of Lillebaelt Hospital page '''NCTID''': NCT05573022 '''Title''': Impact of a Patient Decision Aid Intervention '''Study Summary''': Studies evaluating decisions aids have used a wide range of outcome measures as well as formats and settings. Most studies have focused on patient decision aids used either within the consultation or delivered pre-consultation, but t...")
20:47, 1 December 2023 Francine talk contribs created page Trials (Tartu University Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Tartu University Hospital page '''NCTID''': NCT04241185 '''Title''': Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) '''Study Summary''': This study is designed to assess the antitumor efficacy and safety of pembrolizumab in combination with chemoradiotherapy (CRT) versus CRT a...")
20:45, 1 December 2023 Francine talk contribs created page Trials (North Estonia Medical Centre) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to North Estonia Medical Centre '''NCTID''': NCT02205047 '''Title''': Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma '''Study Summary''': The purpose of this study is to find out whether either trastuzumab or the combination of trastuzumab and pertuzumab with standard chemotherapy shows more activity against gastro-oesophageal aden...")
20:39, 1 December 2023 Francine talk contribs created page Trials (East Tallinn Central Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to East Tallinn Central Hospital Trials page '''NCTID''': NCT05152147 '''Title''': A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers '''Study Summary''': This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better t...")
20:38, 1 December 2023 Francine talk contribs created page Trials (East Tallinn Central Hospital Trials) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to East Tallinn Central Hospital Trials page '''NCTID''': NCT05152147 '''Title''': A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers '''Study Summary''': This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better t...")
20:05, 1 December 2023 Francine talk contribs created page Trials (Helsinki University Hospital Comprehensive Cancer Center) (Created page with "'''NCTID''': NCT04657991 '''Title''': A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma '''Study Summary''': The purpose of this study is to learn about the effects of three study medicines (encorafenib, binimetinib, and pembrolizumab) given together for the treatment of melanoma that: * is advanced or metastatic (spread to other parts of the body); * has a certain type of abnormal...")
19:02, 1 December 2023 Larysse talk contribs created page Data Dictionary: FINRISK (Created page with "Go back to Finland page. {| class="wikitable" ! Variable !! Field Description |- | FR12_2 || Marital status |- | FR02_3 || Education |- | KOULV || Number of years of education |- | K13 || Number of persons in household |- | K14A || Number of persons in household under the age of 7 |- | K14B || Number of persons in household aged between 7 and 16 |- | TULOT || Household incomes |- | AMM || Occupation |- | IKA10 || 10 year age groups |- | IKA || Age =...")
18:06, 30 November 2023 Francine talk contribs created page Trials (Kortrijk Cancer Centre AZ Groeninge) (Created page with "{{forresearchers}} Go back to Kortrijk Cancer Centre AZ Groeninge page Kortrijk Cancer Centre AZ Groeninge Trials")
13:21, 30 November 2023 Victor talk contribs created page Template:Forproviders (Created page with "Category:forproviders")
13:20, 30 November 2023 Victor talk contribs created page Template:Forpolicymakers (Created page with "Category:forpolicymakers")
13:20, 30 November 2023 Victor talk contribs created page Template:Forresearchers (Created page with "Category:forresearchers")
03:26, 30 November 2023 Woloski talk contribs created page Fondazione I.R.C.C.S. Policlinico San Matteo Trials (Created page with "'''NCTID''': NCT05210790 '''Title''': A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera '''Study Summary''': The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV. '''Sponsor''': Protagonist Therapeutics, Inc. '''Intervention''': Placebo '''Start Date''': 2022-04-01 '''Last Updated''': 2023-11-09 '''Number of Patients''': 250...")
03:23, 30 November 2023 Woloski talk contribs created page Istituto Nazionale Tumori Regina Elena & Istituto Dermatologico San Gallicano Trials (Created page with "'''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, and advanced terminal stages. Clinical studies and real-world data show that the use of Patient Reported Outcome Measures (PR...")
03:17, 30 November 2023 Woloski talk contribs created page Fondazione Policlinico Universitario Agostino Gemelli IRCCS Trials (Created page with "'''NCTID''': NCT05323656 '''Title''': A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) '''Study Summary''': The primary objective of this study is to compare the change in tumour size per Response Evaluation Criteria in Solid Tumours Version 1.1 (RECIST v1.1) in recurrent or metastatic SCCHN patients treated with setanaxib and pembrolizumab versus patients treated with pl...")
03:14, 30 November 2023 Woloski talk contribs created page IRCCS - Romagna Institute for the Study of Cancer 'Dino Amadori' Trials (Created page with "'''NCTID''': NCT04775290 '''Title''': Yoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy '''Study Summary''': The study aims to investigate, through serial measurements of some biomarkers, the potential mechanisms through which yoga impacts on QOL and fatigue. '''Sponsor''': Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori '''Intervention''': Yoga lessons '''Start Date''': 2019-08-02...")